Skip to content

Pharmaceutical industries Advice

Active
Private limited company (pre-2019)founded 2006active for 20 yearsAvenue Franklin Roosevelt 104, 1330 Rixensart, BelgiumKBO/BCE: BE 0883.798.672
Summary

The computed 12-month bankruptcy probability of Pharmaceutical industries Advice is 4.7% (elevated). For Pharmaceutical industries Advice, at least two annual filings are missing. The 2022 annual accounts show equity of €123,036 and a net result of €3,960. Equity has been shrinking by about 3.3% per year since 2018. Its solvency ranks better than 64% of 14,177 sector peers (NACE 46, financial year 2022). The company has been active since 2006 and the Belgian Official Gazette contains no insolvency or warning signals.

Pharmaceutical industries AdviceActive

Overview

Official details

Source: KBO
Status
Active since 27-09-2006 Normal situation
Registered office
116 active companies are registered at this address 6 started in the 12 months before. Source: KBO register, as of 4 November 2026.
Activity
Wholesale of pharmaceutical and medical goods NACE 46460and 1 other
Establishment unit
2.156.557.151 1330 Rixensart, since 09-10-2006
Financial year end
31 December
Peppol
Reachable since 20-11-2020

Board and ownership

Board
  • SAIVE RobertDirector

Financial position

Bankruptcy probabilitywithin 12 months
4.7%
2022 figures too old to score
Annual accounts 2022
Gross margin
€4,284
Turnover
≈ €42,000
estimated
Profit
€3,960
Equity
€123,036
Total assets
€228,077
  • 2023 accounts not filed, 826 days past the deadline
Signalsraises riskFigures for financial year 2022 (filed on 12-10-2023)3 financial years not filed after the legal deadline; last filed accounts filed 69 days late; 3 of the last 3 accounts lateSize: total assets €228,077Two or more financial years not filed2022 accounts filed 69 days latelowers riskFounded in 2006Show the evidence

Bankruptcy probability

No current score
Figures too old
The latest figures are for FY 2022. They are too old for a current score.
Bankruptcy probability: Elevated
Filing: At least two annual filings are missing
Financial strength, FY 2022 · tick: 2020
Strong
Solvency 79-16
equity 53.9% of total assets
Liquidity 64+1
short-term debt 46.1% · cash 29.0%
Profitability 71+66
return on assets 1.7%
Bankruptcy probability within 12 months
4.7% Elevated
0%0.5%1.5%4%10%≥ 25%

About 5 in 100 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.4% (26,900 companies, NACE 46, micro)
Last 24 months 12-2024: 1.3%lowest value 01-2025: 3.0%▲ +1.7 percentage points vs 12-2024 02-2025: 3.0%● unchanged vs 01-2025 03-2025: 3.2%▲ +0.2 percentage points vs 02-2025 04-2025: 2.9%▼ -0.3 percentage points vs 03-2025 05-2025: 2.9%● unchanged vs 04-2025 06-2025: 2.9%● unchanged vs 05-2025 07-2025: 2.9%● unchanged vs 06-2025 08-2025: 4.3%▲ +1.4 percentage points vs 07-2025 09-2025: 4.3%● unchanged vs 08-2025 10-2025: 4.3%● unchanged vs 09-2025 11-2025: 5.0%▲ +0.7 percentage points vs 10-2025highest value 12-2025: 5.0%● unchanged vs 11-2025highest value 01-2026: 5.0%● unchanged vs 12-2025highest value 02-2026: 5.0%● unchanged vs 01-2026highest value 03-2026: 5.0%● unchanged vs 02-2026highest value 04-2026: 5.0%● unchanged vs 03-2026highest value 05-2026: 5.0%● unchanged vs 04-2026highest value 06-2026: 5.0%● unchanged vs 05-2026highest value 07-2026: 5.0%● unchanged vs 06-2026highest value 08-2026: 4.7%▼ -0.3 percentage points vs 07-2026 09-2026: 4.7%● unchanged vs 08-2026 10-2026: 4.7%● unchanged vs 09-2026 11-2026: 4.7%● unchanged vs 10-2026
Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Six signals.
lowers riskraises risk
raises risk · Figures for financial year 2022 (filed on 12-10-2023)
NBB · annual accounts
raises risk · 3 financial years not filed after the legal deadline; last filed accounts filed 69 days late; 3 of the last 3 accounts late
NBB · filings
lowers risk · Founded in 2006
Companies that have existed this long fail less often. How much that weighs depends on the rest of the company's profile.
KBO
raises risk · Size: total assets €228,077
Companies of this size fail more often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
raises risk · Two or more financial years not filed
Since the financial year that closed on 31-12-2023, 3 financial years are missing at the National Bank. A company this far behind goes bankrupt within the year nineteen times as often as a punctual filer.
NBB · 10 filings
Position against the passed deadline
31-12-2023 year end31-07-2024 deadline04-11-2026 today
raises risk · 2022 accounts filed 69 days late
The financial year that closed on 31-12-2022 was due by 31-07-2023 and was filed on 08-10-2023, 69 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.
NBB · 10 filings
Deviation from the deadline
2025
not filed
2024
not filed
2023
not filed
2022
69 days late
2020
117 days late
2019
98 days late
2018
28 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 4 accounts on average 78 days after the deadline. In the sector (NACE 46), the median for financial year 2024 was 3 days before the deadline, and 39% of those companies filed late.

Searched, nothing found (1)
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Recent changes

  1. · Gazette deed Incorporation
All 13 events

Comparable companies

These companies have the same main activity as Pharmaceutical industries Advice: wholesale of pharmaceutical and medical goods (NACE 46460). They are comparable in size and age: total assets between €73,900 and €130,000, founded between 1993 and 2011.

CompanyTotal assetsGross margin
Pharmaceutical industries Advice Rixensart€228,077€4,284
HEXACATH BELGIUM Elsene€96,025€6,015
Ulmedt Diepenbeek€87,797€4,316
SCIENCE ET MEDECINE Waterloo€127,922€2,751
LOCRAD Liège€120,940€9,553
EUROHISTOCYT Beveren-Kruibeke-Zwijndrecht€73,853€2,974
L.M.-HOLDING Dilbeek€130,173€12,164
Full comparison

Key facts about Pharmaceutical industries Advice

What is the company number of Pharmaceutical industries Advice?
The company number of Pharmaceutical industries Advice is 0883.798.672. The VAT number is the same number with BE in front: BE 0883.798.672.
Where is Pharmaceutical industries Advice based?
The registered office is at Avenue Franklin Roosevelt 104, 1330 Rixensart.Company details
What does Pharmaceutical industries Advice do?
According to the KBO register, the main activity is wholesale of pharmaceutical and medical goods (NACE 46460).
What is the legal form of Pharmaceutical industries Advice?
The legal form of Pharmaceutical industries Advice is Private limited company (pre-2019) (BVBA).
When was Pharmaceutical industries Advice founded?
Pharmaceutical industries Advice was founded on 27-09-2006.
Is Pharmaceutical industries Advice still active?
Yes, Pharmaceutical industries Advice is an active enterprise in the KBO register.
What is the turnover of Pharmaceutical industries Advice?
The turnover in financial year 2022 is ≈ €42,000. This figure is estimated from the gross margin of €4,284 and 42 comparable companies (NACE 464). It probably lies between €22,000 and €160,000. It is a rough estimate.Financials
Is Pharmaceutical industries Advice profitable?
In financial year 2022, Pharmaceutical industries Advice made a profit of €3,960.
Where can I find the annual accounts of Pharmaceutical industries Advice?
Pharmaceutical industries Advice filed 15 annual accounts with the National Bank of Belgium, the latest for financial year 2022.

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.